Outputs for Dana-Farber Cancer Institute (DFCI)

1 August 2019 - 31 July 2020

United States of America (USA)

Country: United States Of America (USA)

Sector: Healthcare

Subject/journal group: All

Count Share
420 54.79

The research outputs below are grouped by journal. Click on the journal to view the list of articles.

Journal Count Share
ACS Nano 6 0.41
Advanced Functional Materials 9 0.22
Advanced Materials 5 0.11
American Journal of Human Genetics 2 0.69
Analytical Chemistry 2 0.27
Angewandte Chemie International Edition 6 0.99
Cancer Cell 13 3.22
Cancer Research 16 3.90
Cell 15 2.43
Cell Host & Microbe 1 0
Cell Metabolism 4 0.23
Cell Stem Cell 13 2.02
Chemical Communications 2 0.02
Chemical Science 1 0.03
Current Biology 1 0.01
Developmental Cell 5 0.19
Genes & Development 5 0.52
Genome Research 2 0.04
Immunity 3 0.17
Journal of Biological Chemistry 6 2.20
Journal of Cell Biology 2 0.76
Journal of Clinical Investigation 12 1.24
Journal of Experimental Medicine 3 0.81
Journal of Neuroscience 1 0.01
Journal of the American Chemical Society 3 0.55
Molecular Cell 10 1.78
Nature 34 3.35
Nature Biotechnology 8 0.88
Nature Cell Biology 8 1.39
Nature Chemical Biology 7 1.33
Nature Chemistry 1 0.05
Nature Communications 80 10.37
Nature Genetics 19 2.54
Prostate cancer reactivates developmental epigenomic programs during metastatic progression
2020-07-20
0.51
Discovery of regulatory noncoding variants in individual cancer genomes by using cis-X
2020-07-06
0.02
Selective Mediator dependence of cell-type-specifying transcription
2020-06-01
0.08
Cas9 activates the p53 pathway and selects for p53-inactivating mutations
2020-05-18
0.35
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
2020-05-18
0
Quantifying genetic effects on disease mediated by assayed gene expression levels
2020-05-18
0.08
Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma
2020-03-23
0.11
Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution
2020-03-05
0
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
2020-02-05
0.03
Early TP53 alterations engage environmental exposures to promote gastric premalignancy in an integrative mouse model
2020-02-05
0.63
Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
2020-02-05
0.03
The landscape of viral associations in human cancers
2020-02-05
0.01
Identification of cancer driver genes based on nucleotide context
2020-02-03
0.28
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation
2020-01-20
0.08
ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer
2020-01-13
0.08
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
2020-01-07
0
RNA isoform screens uncover the essentiality and tumor-suppressor activity of ultraconserved poison exons
2020-01-07
0.08
Stalled developmental programs at the root of pediatric brain tumors
2019-11-25
0.01
Mutations in alter KRAS prenylation and are associated with hereditary pancreatic cancer
2019-08-12
0.15
Nature Immunology 4 0.68
Nature Materials 1 0.12
Nature Medicine 16 2.43
Nature Methods 5 0.20
Nature Nanotechnology 1 0.03
Nature Neuroscience 2 0.02
Nature Structural & Molecular Biology 2 0.86
PLOS Biology 1 0
PLOS Genetics 2 0.08
Physical Review Letters 1 0.01
Proceedings of the National Academy of Sciences of the United States of America 26 3.29
Proceedings of the Royal Society B 1 0.01
Science 13 1.49
Science Advances 26 1.90
Science Translational Medicine 8 0.25
The ISME Journal: Multidisciplinary Journal of Microbial Ecology 1 0.02
eLife 5 0.67

Return to institution outputs